What if the decades of progress against cancer — the breakthroughs, the rising survival rates, the new vaccines and cutting‑edge therapies — were suddenly put in jeopardy? Five decades after the “war on cancer” began, the hard‑won momentum now faces existential threats: canceled grants and clinical trials, proposals to slash the NCI budget, and an unprecedented politicization of biomedical research funding.

Victoria Goldberg is joined by Pam Traxel, Senior Vice President at the American Cancer Society and a lifelong patient advocate.